Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Liabilities and Shareholders Equity (2022 - 2025)

OneMedNet (ONMD) has disclosed Liabilities and Shareholders Equity for 4 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 65.68% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.3 million, a 40.03% increase, with the full-year FY2024 number at $3.7 million, up 703.23% from a year prior.
  • Liabilities and Shareholders Equity was $1.5 million for Q3 2025 at OneMedNet, down from $2.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $120.4 million in Q3 2022 to a low of $464000.0 in Q4 2023.
  • A 4-year average of $30.2 million and a median of $3.7 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 703.23% in 2024; the steepest drop was 97.48% in 2024.
  • OneMedNet's Liabilities and Shareholders Equity stood at $1.3 million in 2022, then tumbled by 64.0% to $464000.0 in 2023, then surged by 703.23% to $3.7 million in 2024, then tumbled by 59.59% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Liabilities and Shareholders Equity are $1.5 million (Q3 2025), $2.3 million (Q2 2025), and $1.7 million (Q1 2025).